Bluebird Bio Stock Analysis: AI Model Signals Bearish Trend

Intuitive Code AI urges selling short Bluebird Bio (BLUE), betting against Goldman Sachs. Bluebird Bio (BLUE) is Intuitive Code's number-one biotech investing idea for short-sellers.

We're selling shares of Bluebird Bio, downgrading to sell in real-time at $217, while Goldman Sachs is upgrading to $309. Bluebird Bio is likely to report an astonishing earnings miss next quarter. Short sellers are looking at a multi-million profit going into 2018.